Audio is streamed directly from the publisher (dts.podtrac.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Dr. Amin Kherani discusses the Clarity study which compares use of intravitreal aflibercept injections versus PRP laser for proliferative diabetic retinopathy. We also briefly discuss DRCR.net protocol S results that compare intravitreal ranibizumab versus PRP laser for the same indication.
Full reference of the Clarity article:
Clinical efficacy of intravitreal aflibercept versus panretinal photocoagulation for best corrected visual acuity in patients with proliferative diabetic retinopathy at 52 weeks (CLARITY): a multicentre, single-blinded, randomised, controlled, phase 2b, non-inferiority trial. Sivaprasad, SobhaBhatnagar, A et al. The Lancet , Volume 389 , Issue 10085 , 2193 - 2203